Severity
Moderate
ModerateActive
CPSC recall · Reported December 18, 2009
Vicks Dayquil Cold & Flu Liquicaps Recalled by Procter & Gamble Due To Failure to Meet Child-Resistant Closure Requirement
The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statement, "This Package for Households Without Young Children," as required…
Compiled from official public sources by the editorial team.
Verify with CPSC →
The Procter & Gamble Co., of Cincinnati, Ohio recalled The recall involves Vicks Dayquil Cold & Flu 24-Count Bonus Pack Liquicaps. The medicine … - a moderate-severity action.
Vicks Dayquil Cold & Flu Liquicaps Recalled by Procter & Gamble Due To Failure to Meet Ch… was recalled by The Procter & Gamble Co., of Cincinnati, Ohio in December 18, 2009. Reason: The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statem…. Remedy: Consumers should keep this product out of the reach of children. Consumers who purchased …. Verify recall #10085 with the CPSC before acting.
The recall
The Procter & Gamble Co., of Cincinnati, Ohio issued this moderate-severity CPSC recall-The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statem….
- Moderate
- severity level
- December 18, 2009
- reported
Sourced from official CPSC enforcement records. Verify recall #10085 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This CPSC action (record #10085) was formally reported on December 18, 2009. It is classified under Moderate severity, with a current status of Active. The Procter & Gamble Co., of Cincinnati, Ohio is listed as the recalling firm. Federal records list the affected scope as About 700,000 packages.
The documented reason for this recall is: The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statement, "This Package for Households Without Young Children," as required by the Poison Prevention Packaging Act.… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should keep this product out of the reach of children. Consumers who purchased the product with the expectation that it would be in child-resistant packaging can contact Procter & Gamble fo… - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
About 700,000 packages
Related Recalls
6
0 from same agency
Product description
The recall involves Vicks Dayquil Cold & Flu 24-Count Bonus Pack Liquicaps. The medicine comes in orange packaging with the green Vicks symbol and has the following UPC#: 3 23900 01087 1. No other Vick's product is included in this recall.
Reason for recall
The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statement, "This Package for Households Without Young Children," as required by the Poison Prevention Packaging Act. This medicine could cause serious health problems or death to a child if several of the capsules are swallowed.
Remedy, what to do
Consumers should keep this product out of the reach of children. Consumers who purchased the product with the expectation that it would be in child-resistant packaging can contact Procter & Gamble for a full refund or a replacement coupon. Adult consumers can continue to use the product as directed.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 10085 |
| Date reported | December 18, 2009 |
| Date initiated | December 18, 2009 |
| Recalling firm | The Procter & Gamble Co., of Cincinnati, Ohio |
| Affected scope | About 700,000 packages |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should keep this product out of the reach of children. Consumers who purchased the product with the expectation that it…
- Check the recall number (10085) and product description against the item you own. Search the archive
- Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
The recall involves Vicks Dayquil Cold & Flu 24-Count Bonus Pack Liquicaps. The medicine comes in orange packaging with the green Vicks symbol and has the following UPC#: 3 23900 01087 1. No other Vick's product is included in this recall.. Recalled by The Procter & Gamble Co., of Cincinnati, Ohio. Units affected: About 700,000 packages.
Why was this product recalled? ▼
The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statement, "This Package for Households Without Young Children," as required by the Poison Prevention Packaging Act. This medicine could cause serious health problems or death to a child if several of the capsules are swallowed.
What should consumers do? ▼
Consumers should keep this product out of the reach of children. Consumers who purchased the product with the expectation that it would be in child-resistant packaging can contact Procter & Gamble for a full refund or a replacement coupon. Adult consumers can continue to use the product as directed.
Which agency issued this recall? ▼
This recall was issued by the CPSC on December 18, 2009. Severity: Moderate. Recall number: 10085.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (10085) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product? ▼
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
FDA Drug Low
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie c…
AbbVie Inc. · 2026-06-03
FDA Food Moderate
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET modern round 24-400 bot…
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
FDA Drug Moderate
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by:…
Safecor Health, LLC · 2026-05-27
FDA Drug Moderate
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3…
IntegraDose Compounding Services LLC · 2026-05-27
FDA Drug Moderate
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, …
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported December 18, 2009. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.